Brahms AG
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Risk Stratification Using Midregional Proadrenomedullin in the ED (NCT05108883) | Brahms AG | 2021-10-14 |
| Identifying Patients With Suspicion of Infection in the ED Who Have Low Disease Severity Using MR-proADM - Pilot Study (NCT03770533) | Brahms AG | 2018-12-14 |
Track Brahms AG automatically
Every clearance here is in the API, with alerts when new ones post.